Published in Nat Clin Pract Endocrinol Metab on June 01, 2006
Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol (2011) 6.53
Gender differences in insulin resistance, body composition, and energy balance. Gend Med (2009) 3.19
The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol (2010) 2.50
Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene. Diabetes (2009) 2.36
Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes. PLoS Med (2007) 2.17
Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci (2014) 2.03
Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS One (2008) 2.02
Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. World J Gastroenterol (2009) 1.68
Molecular mechanisms of alcoholic fatty liver. Alcohol Clin Exp Res (2008) 1.59
Relationships of circulating sex hormone-binding globulin with metabolic traits in humans. Diabetes (2010) 1.43
The metabolically benign and malignant fatty liver. Diabetes (2011) 1.39
Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes. Diabetes Care (2011) 1.36
Circulating palmitoleate strongly and independently predicts insulin sensitivity in humans. Diabetes Care (2009) 1.36
Immunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA/KORA Augsburg case-cohort study. PLoS One (2011) 1.35
Resveratrol as a calorie restriction mimetic: therapeutic implications. Trends Cell Biol (2012) 1.26
Liver fat content determined by magnetic resonance imaging and spectroscopy. World J Gastroenterol (2010) 1.25
The role of hepatokines in metabolism. Nat Rev Endocrinol (2013) 1.21
The association of PNPLA3 variants with liver enzymes in childhood obesity is driven by the interaction with abdominal fat. PLoS One (2011) 1.18
Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance. Dig Dis Sci (2011) 1.16
Mice with a targeted deletion of the type 2 deiodinase are insulin resistant and susceptible to diet induced obesity. PLoS One (2011) 1.15
Short-term exercise training does not stimulate skeletal muscle ATP synthesis in relatives of humans with type 2 diabetes. Diabetes (2009) 1.15
Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease. J Lipid Res (2008) 1.14
Small molecule glucokinase activators disturb lipid homeostasis and induce fatty liver in rodents: a warning for therapeutic applications in humans. Br J Pharmacol (2013) 1.14
Liver and diabetes. A vicious circle. Hepatol Res (2013) 1.10
Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model. PLoS One (2011) 1.08
The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies. PLoS One (2011) 1.08
Mechanisms and clinical implications of hepatocyte lipoapoptosis. Clin Lipidol (2010) 1.07
Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans. Lipids Health Dis (2011) 1.02
Impaired mitochondrial function and insulin resistance of skeletal muscle in mitochondrial diabetes. Diabetes Care (2009) 1.01
Linagliptin improves insulin sensitivity and hepatic steatosis in diet-induced obesity. PLoS One (2012) 1.01
Saturated fatty acids activate ERK signaling to downregulate hepatic sortilin 1 in obese and diabetic mice. J Lipid Res (2013) 1.01
Tuberous sclerosis complex-1 deficiency attenuates diet-induced hepatic lipid accumulation. PLoS One (2011) 1.00
Fatty liver index predicts further metabolic deteriorations in women with previous gestational diabetes. PLoS One (2012) 1.00
Phenotypic comparison of common mouse strains developing high-fat diet-induced hepatosteatosis. Mol Metab (2013) 1.00
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age? World J Gastroenterol (2014) 0.93
Hepatocellular proliferation correlates with inflammatory cell and cytokine changes in a murine model of nonalchoholic fatty liver disease. PLoS One (2013) 0.90
Impact of different fat depots on insulin sensitivity: predominant role of liver fat. J Diabetes Sci Technol (2007) 0.90
Impact of the adipokine adiponectin and the hepatokine fetuin-A on the development of type 2 diabetes: prospective cohort- and cross-sectional phenotyping studies. PLoS One (2014) 0.89
NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages. Nat Med (2016) 0.88
Increased saturated fatty acids in obesity alter resolution of inflammation in part by stimulating prostaglandin production. J Immunol (2013) 0.88
Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver. Diabetes Care (2013) 0.88
Topiramate-induced modulation of hepatic molecular mechanisms: an aspect for its anti-insulin resistant effect. PLoS One (2012) 0.88
Palmitic acid induces osteoblastic differentiation in vascular smooth muscle cells through ACSL3 and NF-κB, novel targets of eicosapentaenoic acid. PLoS One (2013) 0.88
Mitochondrial trifunctional protein defects: clinical implications and therapeutic approaches. Adv Drug Deliv Rev (2008) 0.88
Hepatic steatosis in type 1 diabetes. Rev Diabet Stud (2012) 0.87
Coordinated defects in hepatic long chain fatty acid metabolism and triglyceride accumulation contribute to insulin resistance in non-human primates. PLoS One (2011) 0.87
Selective hepatic insulin resistance in a murine model heterozygous for a mitochondrial trifunctional protein defect. Hepatology (2013) 0.86
Effects of high-dose simvastatin therapy on glucose metabolism and ectopic lipid deposition in nonobese type 2 diabetic patients. Diabetes Care (2008) 0.85
Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndrome. Mediators Inflamm (2013) 0.85
Diabetes Mellitus Predicts Occurrence of Cirrhosis and Hepatocellular Cancer in Alcoholic Liver and Non-alcoholic Fatty Liver Diseases. J Clin Transl Hepatol (2015) 0.83
Reduced basal ATP synthetic flux of skeletal muscle in patients with previous acromegaly. PLoS One (2008) 0.82
Reduced hepatic aquaporin-9 and glycerol permeability are related to insulin resistance in non-alcoholic fatty liver disease. Int J Obes (Lond) (2013) 0.81
Severity of non-alcoholic fatty liver disease is associated with high systemic levels of tumor necrosis factor alpha and low serum interleukin 10 in morbidly obese patients. Clin Exp Med (2015) 0.80
Comparison of liver fat indices for the diagnosis of hepatic steatosis and insulin resistance. PLoS One (2014) 0.80
Enforced expression of protein kinase C in skeletal muscle causes physical inactivity, fatty liver and insulin resistance in the brain. J Cell Mol Med (2010) 0.80
Hepatogenous diabetes in cirrhosis is related to portal pressure and variceal hemorrhage. Dig Dis Sci (2013) 0.79
Subclinical abnormal glucose tolerance is a predictor of death in liver cirrhosis. World J Gastroenterol (2014) 0.78
Direct inhibitory effects of pioglitazone on hepatic fetuin-A expression. PLoS One (2014) 0.78
NAFLD and diabetes mellitus. Nat Rev Gastroenterol Hepatol (2016) 0.77
Deficient copper concentrations in dried-defatted hepatic tissue from ob/ob mice: A potential model for study of defective copper regulation in metabolic liver disease. Biochem Biophys Res Commun (2015) 0.77
Liver fat, statin use, and incident diabetes: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis (2015) 0.77
Cohort profile: the German Diabetes Study (GDS). Cardiovasc Diabetol (2016) 0.77
Hepatic glucose production and insulin resistance. Wien Med Wochenschr (2008) 0.77
Habitually higher dietary glycemic index during puberty is prospectively related to increased risk markers of type 2 diabetes in younger adulthood. Diabetes Care (2013) 0.77
Effects of glucose-6-phosphate dehydrogenase deficiency on the metabolic and cardiac responses to obesogenic or high-fructose diets. Am J Physiol Endocrinol Metab (2012) 0.77
Molecular and immunohistochemical effects of metformin in a rat model of type 2 diabetes mellitus. Exp Ther Med (2015) 0.77
A possible link between hepatic mitochondrial dysfunction and diet-induced insulin resistance. Eur J Nutr (2016) 0.77
Low alcohol consumption increases the risk of impaired glucose tolerance in patients with non-alcoholic fatty liver disease. J Gastroenterol (2016) 0.76
Glial cell line-derived neurotrophic factor protects against high-fat diet-induced hepatic steatosis by suppressing hepatic PPAR-γ expression. Am J Physiol Gastrointest Liver Physiol (2015) 0.76
Regulation of type 2 diabetes by helminth-induced Th2 immune response. J Vet Med Sci (2016) 0.76
ADV36 adipogenic adenovirus in human liver disease. World J Gastroenterol (2014) 0.76
Clinical features of patients with type 2 diabetes mellitus and hepatitis C infection. Braz J Med Biol Res (2012) 0.76
Acetylcholinesterase (AChE) inhibition aggravates fasting-induced triglyceride accumulation in the mouse liver. FEBS Open Bio (2014) 0.75
p110α Hot Spot Mutations E545K and H1047R Exert Metabolic Reprogramming Independently of p110α Kinase Activity. Mol Cell Biol (2015) 0.75
Effect of Atorvastatin on Glycaemic Parameters in Normoglycaemic and Prediabetic Subjects: A Prospective, Panel Study. J Clin Diagn Res (2017) 0.75
Diabetes diminishes the portal-systemic collateral vascular response to vasopressin via vasopressin receptor and Gα proteins regulations in cirrhotic rats. PLoS One (2013) 0.75
A Computational Model of Hepatic Energy Metabolism: Understanding Zonated Damage and Steatosis in NAFLD. PLoS Comput Biol (2016) 0.75
Associations of A-FABP with Anthropometric and Metabolic Indices and Inflammatory Cytokines in Obese Patients with Newly Diagnosed Type 2 Diabetes. Biomed Res Int (2016) 0.75
Associations between longer habitual day napping and non-alcoholic fatty liver disease in an elderly Chinese population. PLoS One (2014) 0.75
Lipidomics-Reshaping the Analysis and Perception of Type 2 Diabetes. Int J Mol Sci (2016) 0.75
Probable NAFLD, by ALT levels, and diabetes among Filipino-American women. Diabetes Res Clin Pract (2007) 0.75
Association between diabetes mellitus and cirrhosis mortality: the Singapore Chinese Health Study. Liver Int (2016) 0.75
In-vivo (31)P-MRS of skeletal muscle and liver: A way for non-invasive assessment of their metabolism. Anal Biochem (2017) 0.75
The Low-Dose (7.5 mg/day) Pioglitazone Therapy. J Clin Med Res (2017) 0.75